Drugs / MINTOX® Maximum Strength
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01622673 | Jun → Oct 2012 | HIV infectious disease | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MINTOX Maximum Strength | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01622673 ↗ |